Welcome to our dedicated page for Ardent Health Partners news (Ticker: ARDT), a resource for investors and traders seeking the latest updates and insights on Ardent Health Partners stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Ardent Health Partners's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Ardent Health Partners's position in the market.
Ardent Health (NYSE: ARDT) has appointed Dave Styblo as senior vice president of investor relations. Styblo, with over 20 years of investment experience, will oversee Ardent's investor relations program and serve as the primary liaison with investors, analysts, and financial partners. His background includes roles as a sell-side analyst at Jefferies focusing on healthcare services and managed care stocks, and as an independent investor relations advisor to healthcare companies.
Styblo's appointment comes as Ardent begins its journey as a public company. Alfred Lumsdaine, Ardent Health's CFO, expressed confidence that Styblo's deep experience and industry knowledge will be valuable in building strong relationships and communicating Ardent's story to the investment community.
Ardent Health Partners (NYSE: ARDT) announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference from September 4-6, 2024, in New York. CEO Marty Bonick and CFO Alfred Lumsdaine will engage in a fireside chat on September 5 at 10:00 a.m. ET. The presentation will be livestreamed on Ardent Health's Investor Relations website, with a 90-day replay available.
The management team will also be available for one-on-one meetings with registered investors. Ardent Health, a leading healthcare provider in growing mid-sized urban communities across the U.S., offers this opportunity for investors to gain insights into their operations and strategy.
Ardent Health Partners (NYSE: ARDT) reported strong Q2 2024 results with total revenue of $1.47 billion, up 7.5% year-over-year. Net income attributable to Ardent was $43 million, or $0.34 per share. Adjusted EBITDA increased 20% to $122 million. The company saw a 3.4% increase in adjusted admissions and a 4.1% rise in net patient service revenue per adjusted admission.
Ardent completed its IPO in July, raising $209 million in net proceeds. For full-year 2024, the company projects revenue between $5.75-$5.90 billion and Adjusted EBITDA of $415-$435 million. The guidance reflects expected adjusted admissions growth of 4.0-4.5% and net patient service revenue per adjusted admission growth of 2.3-4.4%.
Ardent Health Partners (NYSE: ARDT) has announced the date for its second quarter 2024 results conference call and webcast. The company will release its financial results after market close on Wednesday, August 14, 2024. A conference call to discuss the results will be held on Thursday, August 15, 2024, at 10:00 a.m. ET. Investors can access the webcast and presentation materials through Ardent's Investor Relations website. To participate in the live teleconference, US callers can dial 1-888-596-4144, while international callers should use 1-646-968-2525, with the access code 4437657. A replay of the call will be available until August 22, 2024.
Ardent Health Partners (NYSE: ARDT) has successfully closed its initial public offering (IPO) of 12,000,000 shares of common stock at $16 per share, raising approximately $192 million in gross proceeds. The company has granted underwriters a 30-day option to purchase an additional 1,800,000 shares. Ardent Health, a leading healthcare provider in growing midsize urban communities across the U.S., began trading on the New York Stock Exchange on July 18, 2024, under the ticker symbol 'ARDT'.
The company plans to use the net proceeds for working capital, acquisitions, debt repayment, and capital expenditures. J.P. Morgan, BofA Securities, and Morgan Stanley acted as lead book-running managers for the offering, with several other firms participating as bookrunners and co-managers.
FAQ
What is the current stock price of Ardent Health Partners (ARDT)?
What is the market cap of Ardent Health Partners (ARDT)?
